Department of Health and Human Services August 11, 2011 – Federal Register Recent Federal Regulation Documents

CooperVision, Inc.; Filing of Color Additive Petitions
Document Number: C1-2011-16089
Type: Proposed Rule
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
Request for Nominations of Candidates To Serve on the Advisory Committee on Immunization Practices (ACIP)
Document Number: 2011-20479
Type: Notice
Date: 2011-08-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
Document Number: 2011-20473
Type: Notice
Date: 2011-08-11
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Government-Owned Inventions; Availability for Licensing
Document Number: 2011-20447
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Food and Drug Administration/National Heart, Lung, and Blood Institute/National Science Foundation Public Workshop on Computer Methods for Medical Devices
Document Number: 2011-20446
Type: Notice
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing a public workshop entitled ``FDA/NHLBI/NSF Workshop on Computer Methods for Medical Devices.'' FDA is cosponsoring the conference workshop with the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health and the National Science Foundation (NSF). The purpose of the workshop is to facilitate discussion between FDA and other interested parties on the use of computational modeling in the design, development and evaluation of medical devices. Dates and Times: The public workshop will be held on September 7, 8, and 9, 2011, from 9 a.m. to 5 p.m. An optional FDA Microstructure Modeling session will be held from 1 to 5 p.m. on September 6, 2011. Participants are encouraged to arrive early to ensure time for parking and security screening before the meeting. Security screening will begin at 8 a.m. Persons interested in attending this public workshop must register by 5 p.m. on August 30, 2011. Location: The public workshop and optional session will be held at the FDA White Oak Campus, 10903 New Hampshire Ave, Building 31 Conference Center, the Great Room (rm. 1503), Silver Spring, MD 20993- 0002. Contact Persons: Donna R. Lochner, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 62, rm. 3220, Silver Spring, MD 20993-0002, 301-796-6309, e-mail: donna.lochner@fda.hhs.gov; or Tina M. Morrison, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1272, Silver Spring, MD 20993-0002, 301-796-6310, e-mail: tina.morrison@fda.hhs.gov. Registration: To register for the public workshop and optional session, please visit the following Web site: https://www.fda.gov/ MedicalDevices/NewsEvents/WorkshopsConferences/default.htm (or go to https://www.fda.gov and select the FDA Medical Devices News & Events Workshops & Conferences calendar and select this public workshop from the posted events list). Please provide complete contact information for each attendee, including name, title, affiliation, address, email, and telephone number. For those without Internet access, please call the contact person to register. Registration is mandatory as space is limited and onsite registration will not be available. FDA may limit the number of participants from each organization. There is no registration fee for the public workshop. Registrants requesting to present written materials or to make oral presentations at the public workshop, please call the contact persons by August 23, 2011. If you need special accommodations because of a disability, please contact Susan Monahan, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 4321, Silver Spring, MD 20993-0002, 301-796-5661 at least 7 days before the public workshop.
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: 2011-20444
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
Fogarty International Center Notice of Meetings
Document Number: 2011-20442
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 2011-20441
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Nursing Research Notice of Meeting
Document Number: 2011-20440
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
National Library of Medicine; Notice of Closed Meeting
Document Number: 2011-20439
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institutes of Health National Institute of Environmental Health Sciences; Notice of Meeting
Document Number: 2011-20438
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 2011-20437
Type: Notice
Date: 2011-08-11
Agency: Department of Health and Human Services, National Institutes of Health
Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease; Reopening of the Comment Period
Document Number: 2011-20406
Type: Proposed Rule
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is reopening the comment period for the proposed rule published in the Federal Register of December 8, 2010, proposing to amend regulations on plant sterol/ stanol esters and risk of coronary heart disease (CHD). FDA is reopening the comment period because the Agency received a request for additional time to comment on the proposed rule.
Oral Dosage Form New Animal Drugs; Change of Sponsor; Chlortetracycline; Sulfamethazine
Document Number: 2011-20404
Type: Rule
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for five new animal drug applications (NADAs) from Fort Dodge Animal Health, Division of Wyeth Holdings Corp., a wholly owned subsidiary of Pfizer, Inc., to Boehringer Ingelheim Vetmedica, Inc.
Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting
Document Number: 2011-20399
Type: Notice
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
International Conference on Harmonisation; Guidance on E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions; Availability
Document Number: 2011-20386
Type: Notice
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled ``E16 Biomarkers Related to Drug or Biotechnology Product Development: Context, Structure, and Format of Qualification Submissions.'' The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance describes recommendations regarding the context, structure, and format of qualification submissions for clinical and nonclinical genomic biomarkers related to development of drug or biotechnology products, including translational medicine approaches, pharmacokinetics, pharmacodynamics, and efficacy and safety aspects. The guidance is intended to create a harmonized recommended structure for biomarker qualification applications that will foster consistency of applications across regions and facilitate discussions with and among regulatory authorities.
Guidance for Industry: Bar Code Label Requirements-Questions and Answers; Availability
Document Number: 2011-20385
Type: Notice
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a document entitled ``Guidance for Industry: Bar Code Label RequirementsQuestions and Answers'' dated August 2011. The guidance announced in this notice amends the October 2006 guidance document of the same title by incorporating a revised response to question 12 (Q12). The revised response concerns the ability of vaccine manufacturers to use alternative coding technologies to the linear bar code requirement. The guidance announced in this notice finalizes the draft guidance entitled ``Guidance for Industry: Bar Code Label RequirementsQuestions and Answers (Question 12 Update)'' dated August 2010, and is superseding the guidance entitled ``Guidance for Industry: Bar Code Label RequirementsQuestions and Answers'' dated October 2006.
The Development and Evaluation of Next-Generation Smallpox Vaccines; Public Workshop
Document Number: 2011-20367
Type: Notice
Date: 2011-08-11
Agency: Food and Drug Administration, Department of Health and Human Services
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.